← Evidence map

ArticleClinical and experimental nephrology2020

Correction to: Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia.

Satoru KuriyamaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2020
2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31970592